𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B

✍ Scribed by Kun Zhou; Chun-Fang Gao; Yun-Peng Zhao; Hai-Lin Liu; Rui-Dan Zheng; Jian-Chun Xian; Hong-Tao Xu; Yi-Min Mao; Min-De Zeng; Lun-Gen Lu

Book ID
108953802
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
377 KB
Volume
25
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A seven-gene signature (cirrhosis risk s
A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C
✍ Moira Marcolongo; Bradford Young; Francesca Dal Pero; Giovanna Fattovich; Laura πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 2 views

Fibrosis progression is the main determinant of liver disease outcome in chronic hepatitis C, being influenced by environmental and host factors. Recently, a cirrhosis risk score (CRS) based on seven single-nucleotide polymorphisms was proposed as genetic predictor of cirrhosis in hepatitis C. To as

Simple blood tests as noninvasive marker
Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection
✍ Leonardo L. Schiavon; JanaΓ­na L. N. Schiavon; Roberto J. Carvalho Filho; Juliana πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 248 KB πŸ‘ 2 views

HCV infection is common among patients with end-stage renal disease (ESRD) on hemodialysis, and it has been considered an independent risk factor for mortality in this setting. Although liver biopsy in ESRD patients with HCV infection is useful before kidney transplantation, it carries a high risk o

Prediction of significant fibrosis in HB
Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model
✍ Min-De Zeng; Lun-Gen Lu; Yi-Min Mao; De-Kai Qiu; Ji-Qiang Li; Mo-Bin Wan; Cheng- πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 2 views

A model was constructed consisting of clinical and serum variables to discriminate between hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients with and without significant fibrosis (stages 2-4 vs. stages 0-1). Consecutive treatment-naive CHB patients who underwent liver biopsy